Want to track XVIVO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
XVIVO Perfusion AB (XVIVO) Statistics
Valuation metrics
Market Cap 8.74B
Enterprise value 8.41B
Trailing P/E (ttm) 116.43
Forward P/E -
PEG ratio -2.52
Price/Sales (ttm) 10.3
Price/Book (mrq) 3.96
Enterprise Value/Revenue 10.08
Enterprise Value/EBITDA 62.14
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 45.77K
Average volume (90 days) 96.77K
Price summary
52-Week low 160
52-Week high 322.4
Beta -
50-Day moving average 280.46
200-Day moving average 224.34
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.09%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 26.49
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.34
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.78
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 4.52%
Book value per share (mrq) 68.87
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
